|
Volumn 3, Issue , 2006, Pages
|
Natalizumab for induction of remission in Crohn's disease.
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA4 INTEGRIN;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CROHN DISEASE;
HUMAN;
META ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
REVIEW;
TREATMENT FAILURE;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
HUMANS;
INTEGRIN ALPHA4;
RANDOMIZED CONTROLLED TRIALS;
REMISSION INDUCTION;
TREATMENT FAILURE;
|
EID: 33845999959
PISSN: None
EISSN: 1469493X
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (48)
|
References (22)
|